NIH study finds omalizumab relieves seasonal asthma attacks in youth – 1
Narrator: This is NIH Health Matters. I’m Joe Balintfy. Asthma affects approximately 18 million adults and 7 million children in America. Symptoms include wheezing, coughing, chest tightness and shortness of breath. And experts note that many patients require an emergency room visit because of an exacerbation.
Dr. Togias: It's an asthma attack that lasts much longer than a day.
Narrator: Dr. Alkis Togias at the National Institute of Allergy and Infectious Diseases says an exacerbation is when asthma requires added treatment.
Dr. Togias: It is not your everyday worsening of asthma where you use a few more puffs of your inhaler and it goes away.
Narrator: Learn more about asthma exacerbations and research into new treatments at www.niaid.nih.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Audio
NIH Audio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Audio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Audio is a service of the Office of Communications & Public Liaison.